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A chromosomally encoded type VI
secretion system (T6SS), involved in
bacterial competition, is a key
determinant for niche occupancy.
pINV-encoded virulence
determinants include a type III secretion
system (T3SS) involved in host cell
invasion and phagosomal escape, the
actin-polymerizing factor IcsA, a g4c
capsule, and an unusual O-antigen
encoded by genes horizontally acquired
from Plesiomonas shigelloides.
The g4c capsule and O-antigen of
S. sonnei protect the bacteria from a
wide variety of host defence
mechanisms, including phagocytosis,
phagolysosome degradation, and
complement-mediated lysis.
DISEASE FACTS:
S. sonnei causes acute, self-limiting
disease characterized by bloody
diarrhea, fever, and abdominal pain. In-
fections can be life-threatening for chil-
dren under 5 years and can stunt
growth.
S. sonnei spreads via the fecal–oral route,
as ingested bacteria can survive the gastric
acidity and be released in stool.
Outbreaks are often centered around
large events or care facilities. S. sonnei is
also sexually transmitted, particularly
among men who have sex with men.
The main treatment for bacillary
dysentery is rehydration therapy.
Fluoroquinolones, cephalosporins, and
azithromycin are recommended when
antimicrobials are required. However,
resistance is increasingly common and
new antimicrobials are needed.
There is no licensed vaccine.
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Figure 1. Epidemiology of Shigella sonnei. (A) Cases of S. sonnei versus Shigella flexneri. Cases of S. sonnei are increasing
globally. Red indicates countries where S. sonnei is the dominant cause of shigellosis (when compared with S. flexneri). Blue
indicates countries where a higher proportion of S. flexneri is still being reported (although S. sonnei cases may be rapidly
increasing). Data presented according to Thompson et al. (see Literature). (B) Distribution of S. sonnei resistance to first- and
second-line antibiotics. FQR, fluoroquinolone resistance; ESBL, extended-spectrum β-lactamase-producing (i.e., resistant to
third-generation cephalosporins or carbapenems); RSA, reduced sensitivity to azithromycin. Countries are colored according to
antibiotic-resistant cases reported in Table S1 in the supplemental information online.
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(http://creativecommons.org/licenses/by/4.0/).O-antigen-based immunization has
been proposed; it holds particular
promise as S. sonnei has only one
serotype.
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serge.mostowy@lshtm.ac.uk (S. Mostowy).Shigella sonnei is a rod-shaped, Gram-negative facultative intracellular pathogen. It was named ‘Sonne’s
bacillus’ after Carl Olaf Sonne who described it as a causative agent of bacillary dysentery. S. sonnei is
distributed worldwide and represents the most common cause of shigellosis in industrialized regions in
Europe, North America, and Australia. It is currently undergoing expansion in middle-income countries across
Asia, Latin America, and the Middle East. S. sonnei evolved from Escherichia coli to specialize in intracellular
infection of the human gut epithelium, and its genome comprises a 4.99 Mbp circular chromosome and a
216 kbp invasion plasmid (pINV) required for virulence. The chromosome is ~6% smaller than other E. coli
and is punctuated by N300 copies of insertion sequence (IS) elements, whose expansion has degraded the ge-
nome through disruption and deletion of genes. Here we describe the key and disease facts allowing bacteria to
evade host immune defences and to establish infection.td. This is an open access article under the CC BY license
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TAXONOMY AND CLASSIFICATION:
KINGDOM: Bacteria
PHYLUM: Proteobacteria
CLASS: Gammaproteobacteria
ORDER: Enterobacteriales
FAMILY: Enterobacteriaceae
GENUS: Shigella (whole-genome
comparative analysis does not support
distinct genus designation and suggests
placement of Shigella spp. as lineages
within the species Escherichia coli)
SPECIES: Shigella sonnei
SUBSPECIES: S. sonnei is monoclonal.
All circulating strains originated from a
common ancestor in Europe ~1500 AD.
There is only one serogroup (Shigella
serogroup D) consisting of one serotype.
Five distinct subtypes (lineages I–V) have
been identified by whole-genome
sequencing; the common laboratory
strain 53G belongs to lineage II;
however, most clinical isolates now
belong to lineage III.
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Figure 2. Shigella sonnei Virulence Determinants. (A) S. sonnei 53G plated on Congo Red agar. The virulence plasmid (pINV
of S. sonnei is essential for pathogenesis in vivo but is unstable outside the host (and is lost when bacteria are cultured in vitro). As a
result of maintenance or loss of pINV, S. sonnei presents two different phenotypes on Congo Red plates. Black arrows indicate
small smooth red colonies (Phase I S. sonnei). These colonies retain pINV and accumulate Congo Red dye because they expres
a type III secretion system (T3SS). The small smooth phenotype is due to expression of O-antigen (O-Ag). White arrows indicate
large rough white colonies (Phase II S. sonnei). These colonies are unable to accumulate Congo Red and have an irregula
shape because they lose pINV (which encodes both T3SS and O-Ag). In this case, bacteria were plated from a glycerol stock
(originally obtained from a liquid culture of a single Phase I colony) and incubated overnight at 37°C. Grid numbers indicate the
size in centimetres. (B) Schematic representing key S. sonnei virulence determinants. S. sonnei encodes a T3SS crucial for hos
cell invasion; IcsA whichmediates actin-basedmotility; a T6SS crucial for bacterial competition and niche occupancy; a horizontall
acquired g4c capsule and O-antigen involved in resistance to phagocytosis, complement-mediated lysis, and phagolysosoma
degradation. L-AltNAc, 2-acetamido-2-deoxy-L-altruronic acid; D-FucNAc, N-acetyl-2-acetamido-4-amino-2,4-dideoxy-D-fu
cose. Figure adapted from Torraca et al. (see Literature).
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